Insulin Resistance Intervention After Stroke Trial (IRIS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Takeda Pharmaceuticals North America, Inc.
Information provided by (Responsible Party):
Yale University
ClinicalTrials.gov Identifier:
NCT00091949
First received: September 20, 2004
Last updated: August 25, 2015
Last verified: August 2015